We came across a bullish thesis on Ambev S.A. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on ABEV. Ambev S.A.’s share was trading at $2.57 as of December 1st. ABEV’s trailing and forward P/E were 13.45 and 13.26 respectively according to Yahoo Finance.

Pixabay/Public Domain
Ambev appears undervalued, trading at roughly a 23% discount to fair value, implying potential 9% annual alpha if the gap closes within three years. The valuation assumes...



